Cookie-Settings

Here you can see and modify the cookie settings of various tools used on www.advantageaustria.org and related subdomains.


Save settings
Advantage Austria Show navigation

AI tool is helping to make diagnoses and assess risk in cases of COVID-19

Firmenlogo © Symptoma

© Symptoma

May 14, 2020

The AI chatbot tool manufactured by Austrian digital health company Symptoma is helping patients and doctors in their diagnostic work. User statistics and search queries suggest that the tool is now one of the most popular symptom-checkers in the world.

Users can employ targeted questions to check their symptoms step by step in order to arrive at a possible diagnosis. The chatbot is also used to assess the risk of COVID-19 and has been available to the wider public since the end of March. In a test of patients at risk of COVID-19, the tool achieved an accuracy rate of 96.32%. (96.66% sensitivity, 96.31% specificity, n = 1.142).

Symptoma has a 14-year track record in scientific/medical research and data engineering. The European Commission now officially lists the company’s AI chatbot tool as a solution to fight COVID-19 thanks to the latest scientific study. Symptoma co-founder and CEO Jama Nateqi says: “We are delighted that our approach to helping patients with rare diseases is now also being used for COVID-19 screenings.”

This official recognition by the EU Commission brings Symptoma one step closer to its goal of achieving widespread use among healthcare authorities and thus identifying local hotspots of the disease. It is also hoped that researchers will learn more about the particular characteristics of the illness from the data.


Last modified
May 14, 2020

Related links

 
Symptoma
print
©©ADVANTAGE AUSTRIA